Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Jury Out on Immunomodulatory Therapy for Kids with Severe COVID-19

Megan Brooks  |  

“Importantly, if we were to develop a more nuanced understanding of some of these factors, we would be able to develop more cogent therapeutic approaches, including personalized treatment approaches,” they say.

This research had no commercial funding. Dr. Bassiri and Dr. Dulek have indicated no relevant disclosures.

ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Dulek D, Fuhlbrigge RC, Tribble AC, et al. Multidisciplinary guidance regarding the use of immunomodulatory therapies for acute COVID-19 in pediatric patients. J Pediatric Infect Dis Soc. 2020 Aug 18;piaa098. Online ahead of print.

Related Articles
    Bernard Chantal / shutterstock.com

    Diagnostic Challenges of MIS-C

    During the peak of the coronavirus pandemic in Washington, D.C., we were asked to evaluate a 14-year-old boy admitted to the pediatric hospitalist service. He had been healthy until two weeks before, when he noted a sore throat, and soon after he developed fevers and rashes without congestion, shortness of breath, conjunctivitis or swollen lymph…

    Research Helps Explain Idiosyncrasies of COVID-19

    The Basic and Clinical Research Conference session on Rheumatology Complications of Emerging Viral Infections/SARS-CoV-2 presented findings from numerous studies that help explain some of the idiosyncrasies of COVID-19.

    Serological Antibody Tests in COVID-19: Test Reliability and Utility

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…